miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness
暂无分享,去创建一个
Rosette Lidereau | S. Vacher | I. Bièche | R. Lidereau | F. Spyratos | E. Brain | E. Mouret‐Fourme | J. Alberini | Etienne Brain | F. Lerebours | A. Susini | G. Cizeron-Clairac | Emmanuelle Mouret-Fourme | Sophie Vacher | Ivan Bieche | Florence Lerebours | C. Bélichard | Geraldine Cizeron-Clairac | Frédérique Spyratos | Jean-Louis Alberini | Aurelie Susini | Catherine Belichard | G. Cizeron‐Clairac | Aurélie Susini
[1] R. Gatti,et al. ATM is down-regulated by N-Myc–regulated microRNA-421 , 2010, Proceedings of the National Academy of Sciences.
[2] S. Fuqua,et al. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression , 2011, Oncogene.
[3] I. Van der Auwera,et al. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype , 2010, British Journal of Cancer.
[4] G. Hortobagyi,et al. Trends for inflammatory breast cancer: is survival improving? , 2007, The oncologist.
[5] W. Woodward,et al. Identifying factors that impact survival among women with inflammatory breast cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] F. Bertucci,et al. Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy , 2004, Cancer Research.
[7] F. Basile,et al. Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment , 2010, Molecular Cancer Therapeutics.
[8] N. Palanisamy,et al. Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer , 2011, Clinical Cancer Research.
[9] Rosette Lidereau,et al. Molecular Profiling of Inflammatory Breast Cancer , 2004, Clinical Cancer Research.
[10] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[11] Daniel Birnbaum,et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. , 2005, Cancer research.
[12] S. Devesa,et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. , 2005, Journal of the National Cancer Institute.
[13] G. Hortobagyi,et al. Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] F. Bertucci,et al. Immunophenotypic analysis of inflammatory breast cancers: identification of an ‘inflammatory signature’ , 2004, The Journal of pathology.
[15] Sofia D. Merajver,et al. RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast , 2005, Breast Cancer Research and Treatment.
[16] S. Vacher,et al. Quantification of PKC family genes in sporadic breast cancer by qRT‐PCR: Evidence that PKCι/λ overexpression is an independent prognostic factor , 2012, International journal of cancer.
[17] B. Qian,et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1 , 2009, Breast Cancer Research and Treatment.
[18] Luc Y. Dirix,et al. Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis , 2005, Breast Cancer Research and Treatment.
[19] E. van Marck,et al. Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis , 2007, British Journal of Cancer.
[20] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[21] S. Merajver,et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] J. Steitz,et al. Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.
[23] I. Bozzoni,et al. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells , 2008, The EMBO journal.
[24] Y. Mo,et al. Systematic validation of predicted microRNAs for cyclin D1 , 2009, BMC Cancer.
[25] S. Hilsenbeck,et al. Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype , 2006, Clinical Cancer Research.
[26] John W M Martens,et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer , 2008, Proceedings of the National Academy of Sciences.
[27] Edith A Perez,et al. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. , 2011, Trends in molecular medicine.
[28] E. van Marck,et al. Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer , 2008, Clinical Cancer Research.
[29] W. Gong,et al. Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells , 2012, Molecular Cancer Research.
[30] Fang Zhou,et al. A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis , 2011, Clinical Cancer Research.
[31] Anthony Fyles,et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.
[32] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] Daniel Birnbaum,et al. High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes , 2011, PloS one.
[34] Christophe Lemetre,et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer , 2009, Breast Cancer Research.
[35] Ken Saito,et al. Vasculogenic mimicry and pseudo‐comedo formation in breast cancer , 2002, International journal of cancer.
[36] Sakari Knuutila,et al. MicroRNA profiling differentiates colorectal cancer according to KRAS status , 2012, Genes, chromosomes & cancer.
[37] Xian-gui Hu,et al. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. , 2011, Biochemical and biophysical research communications.
[38] Andrea Bild,et al. Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy , 2006, Clinical Cancer Research.
[39] Israel Steinfeld,et al. Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types , 2009, PloS one.
[40] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[41] Hui Li,et al. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. , 2012, Gene.
[42] Rosette Lidereau,et al. BMC Cancer BioMed Central Research article NF-kappa B genes have a major role in Inflammatory Breast Cancer , 2008 .
[43] Leonard D. Goldstein,et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.
[44] D. Greco,et al. Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs , 2011, PloS one.
[45] G. Russo,et al. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome , 2011, Cell Death and Disease.
[46] Luc Y Dirix,et al. Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression Quantification , 2004, Clinical Cancer Research.
[47] C. Croce,et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.
[48] John S Mattick,et al. Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.
[49] Luigi Naldini,et al. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications , 2009, Nature Reviews Genetics.
[50] Y. Qi,et al. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer , 2011, Breast Cancer Research and Treatment.
[51] Seigo Nakamura,et al. Molecular targets for treatment of inflammatory breast cancer , 2009, Nature Reviews Clinical Oncology.